Skip to Content Facebook Feature Image

Department of Health Investigates WT1 Vaccine Sales in Hong Kong

HK

Department of Health Investigates WT1 Vaccine Sales in Hong Kong
HK

HK

Department of Health Investigates WT1 Vaccine Sales in Hong Kong

2026-08-31 23:46 Last Updated At:09-01 11:52

DH follows up seriously on false claims made by medical centres that a vaccine to prevent multiple cancers is available in Hong Kong and urges members of the public not to use unregistered pharmaceutical products

In response to media reports today (August 31) that some medical centres were offering customers a vaccine called "Wilms' tumor 1" (WT1) which is claimed to prevent multiple types of cancer, the Department of Health (DH) is following up the matter seriously. This includes launching enforcement actions and notifying the Mainland authorities and relevant law enforcement department in Hong Kong.

More Images
The Department of Health, Photo source: HKSAR Government Press Releases

The Department of Health, Photo source: HKSAR Government Press Releases

The poster of WT1 vaccine, Photo source: rednote

The poster of WT1 vaccine, Photo source: rednote

WT1 vaccine, Photo source: rednote

WT1 vaccine, Photo source: rednote

The poster of WT1 vaccine, Photo source: rednote

The poster of WT1 vaccine, Photo source: rednote

The Department of Health, Photo source: HKSAR Government Press Releases

The Department of Health, Photo source: HKSAR Government Press Releases

The DH emphasised that the WT1 vaccine is not a registered pharmaceutical product in Hong Kong. Any advertisement claiming to provide this vaccine for cancer prevention constitutes a misleading claim. No person may illegally sell or possess unregistered pharmaceutical products. The DH takes this matter very seriously and will not tolerate such behaviour.

The DH received reports in July alleging that "HK Pacific Asia Medical Centre" and its affiliated organisations were claiming on social media to provide the WT1 vaccine. This was suspected of violating the Pharmacy and Poisons Ordinance (Chapter 138) (the Ordinance). The DH has carried out multiple unannounced inspections of the premises in question and today conducted further unannounced inspections of a total of seven premises across Hong Kong and Kowloon, including the "HK Pacific Asia Medical Centre". The DH has solemnly reminded the persons in charge of the premises concerned that providing any unregistered pharmaceutical products illegally constitutes an offence under the Ordinance, which is a criminal offence punishable by imprisonment. The DH will continue to closely monitor the premises in question and gather relevant intelligence, taking decisive enforcement action against any illegal or activities.

The poster of WT1 vaccine, Photo source: rednote

The poster of WT1 vaccine, Photo source: rednote

The DH reminded the public that the WT1 vaccine is not a registered pharmaceutical product in Hong Kong. Currently, no relevant registration records have been found with drug regulatory authorities in the Chinese Mainland or overseas. Advertisements claiming to provide this vaccine for cancer prevention are misleading and suspected of fraud. Furthermore, any healthcare professional who misleads patients into believing that the unregistered WT1 vaccine has cancer-preventing or anti-cancer effects is in serious breach of professional conduct, as this may cause patients to delay seeking medical treatment. Members of the public should not trust advertisements or rumours lightly. They should also refrain from receiving injections of unknown substances to avoid endangering their health or delaying medical treatment, which could worsen their condition. The DH has also notified the Hong Kong Customs and Excise Department to follow up on cases where unregistered pharmaceutical products may have been illegally imported into Hong Kong.

Furthermore, as the case may involve the professional conduct of registered medical practitioners, the DH has referred it to the Medical Council of Hong Kong for follow-up.

On the other hand, the DH has reviewed the content of the advertisement placed by the companies in question and found that it was suspected of breaching the Undesirable Medical Advertisements Ordinance (UMAO) (Cap. 231). Hence, the DH has already issued warning letters to the relevant companies in accordance with established procedures and mechanisms, and has requested that the content of the relevant advertisements be removed or deleted. The DH has also notified the relevant law enforcement authorities in the Chinese Mainland to follow up on the matter, given the serious health risks to the public that may arise from the publication of these advertisements on social media platforms in the Chinese Mainland.

Under the Ordinance, any product that meets the definition of a "pharmaceutical product" must meet the criteria of safety, efficacy and quality and be registered with the Pharmacy and Poisons Board of Hong Kong before they can be sold in the market. Advanced therapy product, which include gene therapy products, somatic cell therapy products and tissue engineered products, are regulated as pharmaceutical products under the Ordinance. Any person who illegally sells or possesses unregistered pharmaceutical products commits an offence and shall be liable, upon conviction, to a maximum penalty of a fine of $100,000 and two-years' imprisonment.

WT1 vaccine, Photo source: rednote

WT1 vaccine, Photo source: rednote

Furthermore, import and export of pharmaceutical products are controlled under the Import and Export Ordinance (Cap. 60). Any person who imports or exports pharmaceutical product without relevant licence commits an offence, and shall be liable, upon conviction, to a maximum penalty of a fine of $500,000 and two-years' imprisonment.

From 2021 to June 2026, the DH's Drug Office handled 138 cases involving convictions for the sale and/or possession of unregistered pharmaceutical products. The maximum penalty was 10 months' imprisonment (total for all counts of offences) or a fine of up to HK$242,000 (the total fine for all counts of offences).

Under the Undesirable Medical Advertisements Ordinance (UMAO), no person may publish, or cause to be published, advertisements likely to lead to the use of any medicine, surgical appliance or treatment for treating or preventing the diseases or conditions specified in Schedules 1 and 2. Schedule 4 of the UMAO also prohibition/restriction on six groups of claims for orally consumed products, in order to prevent members of the public from seeking inappropriate methods to treat certain serious conditions or diseases, which could result in delayed treatment.

The DH reminded members of the public that, regarding any queries about the prevention and treatment of diseases (including cancers), they should first consult a registered doctor, who will provide professional advice based on individual health condition and the latest medical evidence. The public should not blindly trust unproven medical claims because protecting one's own health is of the utmost importance.

The DH has stepped up public education and awareness campaigns, issuing warning alerts to the public via social media platforms that the WT1 vaccine is not a registered pharmaceutical product in Hong Kong and should not be used indiscriminately. The DH will continue to closely monitor pharmaceutical products on the market, via both online and offline channels, in accordance with established mechanisms. The DH will also take appropriate follow-up action upon receiving intelligence or complaints. Members of the public are encouraged to provide relevant information to the DH by phone at 2961 8989 or by email (enquiries@dh.gov.hk). The DH will conduct joint operations with other law enforcement department as necessary, or refer the cases to the relevant department for follow-up.

Hong Kong's healthcare standards are internationally renowned. The DH will continue to follow up on this incident seriously. Anyone endangering public health under the pretext of cancer prevention will not be tolerated.

The poster of WT1 vaccine, Photo source: rednote

The poster of WT1 vaccine, Photo source: rednote

Hong Kong cinema showcased at Five Flavours Asian Film Festival in Poland

The Hong Kong Economic and Trade Office, Berlin (HKETO Berlin) supports the Five Flavours Asian Film Festival held in Warsaw, Poland, from November 10 to December 6 (Warsaw time).

This year's festival showcases 10 Hong Kong films. In addition to two recent films, "Montages of a Modern Motherhood" and "Another World", the festival has curated a retrospective programme featuring eight classic works by the director and producer Tsui Hark. The screenings are sponsored by the Cultural and Creative Industries Development Agency of the Culture, Sports and Tourism Bureau and the Film Development Fund.

Speaking before the screening of the opening film "A Chinese Ghost Story" produced by Tsui Hark on November 12, the Director of HKETO Berlin, Mr Indiana Wong, highlighted the richness and diversity of Hong Kong cinema. "From action and martial arts to comedy, drama, and socially conscious films, Hong Kong filmmakers have continually pushed creative boundaries while capturing the spirit of Hong Kong. I invite film and creative professionals to come to Hong Kong, and together we can create quality productions."

HKETO Berlin hosted a reception after the screening, attended by about 200 guests from the business and cultural sectors. Mr Wong took the opportunity to introduce the latest developments in Hong Kong. He also shared that, according to the Chief Executive's 2026 Policy Address, the Support Unit for Non-local Film Productions will be set up to provide one-stop services for Chinese Mainland and overseas film crews filming in Hong Kong, attracting more quality film productions to promote Hong Kong.

During the visit, Mr Wong also met with a local chamber of commerce, journalists, and a start-up organisation to promote the advantages of Hong Kong and exchange views on the latest developments and collaboration opportunities.

About HKETO Berlin

HKETO Berlin is the official representative of the Hong Kong Special Administrative Region Government in commercial relations and other economic and trade matters in Germany as well as Austria, Czechia, Hungary, Poland, the Slovak Republic, Slovenia and Switzerland.

Hong Kong cinema showcased at Five Flavours Asian Film Festival in Poland Source: HKSAR Government Press Releases

Hong Kong cinema showcased at Five Flavours Asian Film Festival in Poland Source: HKSAR Government Press Releases

Hong Kong cinema showcased at Five Flavours Asian Film Festival in Poland Source: HKSAR Government Press Releases

Hong Kong cinema showcased at Five Flavours Asian Film Festival in Poland Source: HKSAR Government Press Releases

Hong Kong cinema showcased at Five Flavours Asian Film Festival in Poland Source: HKSAR Government Press Releases

Hong Kong cinema showcased at Five Flavours Asian Film Festival in Poland Source: HKSAR Government Press Releases

Hong Kong cinema showcased at Five Flavours Asian Film Festival in Poland Source: HKSAR Government Press Releases

Hong Kong cinema showcased at Five Flavours Asian Film Festival in Poland Source: HKSAR Government Press Releases

Recommended Articles